Digitisation | May 12, 2026
HealthQuad invests in AI-powered LifeSigns
Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets
Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets
The event will bring together industrial leaders, technology providers, and policymakers to discuss real-world Industrial AI applications in Bangalore
The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru
Designed for high-throughput genomic analysis, the laboratory enables accurate, consistent, and scalable testing, delivering high standards of reporting excellence
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
The deal signals a clear push to expand access to care in underserved regions
The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
The launch coincides with IBS Awareness Month in April
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
